Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  SpineGuard    ALSGD   FR0011464452

SPINEGUARD (ALSGD)
Add to my list  
Mes dernières consult.
Most popular
Manage my lists
  Report  
Delayed Quote. Delayed  - 07/18 05:35:02 pm
1.7 EUR   +5.92%
07/11SPINEGUARD : posts H1 2018 revenue
BU
07/1111-JULY-2018 &N : SpineGuard posts H1 2018 revenue ( PDF version)
PU
07/11SPINEGUARD : 2nd quarter earnings
CO
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Spineguard SA : annual sales release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/01/2018 | 03:15pm CEST

The company will report its revenue for FY 2017 on 01/04/2018. Generally, the company reports sales better than estimates. In recent months, the analysts from Thomson Reuters consensus have revised their sales estimates downward.

Annual sales is expected at 8 M EUR for 2017 (+ 7.2% from 2016). A summary of annual publications and estimates is available below.

Annual results2014201520162017 (e)2018 (e)
Sales
Million €		 Released
Forecast
Spread		4,44
4,70
-5,6%		6,35
6,00
5,8%		7,46
7,00
6,6%
8,00

10,0
Operating income (EBITDA)
Million €		 Released
Forecast
Spread
-3,80
-3,73
-3,00
-24%		-3,31
-4,00
17%
-1,00

-2,00
Operating profit (EBIT)
Million €		 Released
Forecast
Spread		-4,48
-4,00
-12%		-3,97
-4,00
0,65%		-3,63
-4,00
9,2%
-1,00

-2,00
Pre-Tax Profit (EBT)
 		 Released
Forecast
Spread









Net income
Million €		 Released
Forecast
Spread		-4,54
-5,00
9,2%		-3,88
-4,00
3,1%		-4,18
-4,00
-4,5%
-2,00

6,00
EPS
 €		 Released
Forecast
Spread		-1,04
-0,95
-10%		-0,82
-0,74
-11%		-0,83
-0,84
1,2%
-0,26

-0,26
Announcement Date03/26/201503/24/201603/23/2017

© 4-traders.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SPINEGUARD
07/11SPINEGUARD : posts H1 2018 revenue
BU
07/1111-JULY-2018 – 18H00 CET : SpineGuard posts H1 2018 revenue ( PDF version)
PU
07/11SPINEGUARD : 2nd quarter earnings
CO
07/06SPINEGUARD SA : half-yearly sales release
06/14SPINEGUARD : and Adin Dental Implant Systems Announce the Publication of a Precl..
BU
05/03SPINEGUARD : Reinforces the Utility of Its Dynamic Surgical Guidance (DSG®) Tech..
BU
04/1818-APRIL-2018 – 18H00 CET : SpineGuard® Announces first spinal deformity s..
PU
04/18SPINEGUARD : ® Announces First Spinal Deformity Surgery in China with PediGuard®..
BU
04/0505-APRIL-2018 – 18H00 CET : SpineGuard reports its first-quarter 2018 reve..
PU
04/05SPINEGUARD : Reports Q1 2018 Revenue
BU
More news
News from SeekingAlpha
01/04Spineguard reports Q4 results 
2017Spineguard reports Q3 results 
2017Spineguard reports 1H results 
2017Spineguard reports Q1 results 
2017SpineGuard (SPGRF) Presents At Canaccord Genuity 2017 Musculoskeletal Confere.. 
Financials (€)
Sales 2018 10,0 M
EBIT 2018 -2,00 M
Net income 2018 -
Debt 2018 1,00 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 12,35
EV / Sales 2018 1,10x
EV / Sales 2019 0,57x
Capitalization 9,97 M
Chart SPINEGUARD
Duration : Period :
SpineGuard Technical Analysis Chart | ALSGD | FR0011464452 | 4-Traders
Technical analysis trends SPINEGUARD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 5,70 €
Spread / Average Target 255%
EPS Revisions
Managers
NameTitle
Stéphane Bette Chief Executive Officer & Director
Pierre Jérôme Chairman
Manuel Lanfossi Chief Financial & Administrative Officer
Anne-Charlotte Millard Finance Director
Olivier Frezal Vice-President-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
SPINEGUARD-52.09%12
MASIMO CORPORATION19.14%5 232
ASAHI INTECC CO., LTD.10.63%4 996
PENUMBRA INC48.19%4 778
JIANGSU YUYUE MDCL EQPMNT & SPPLY CO LTD--.--%3 017
GETINGE-19.33%2 756
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2018 Surperformance. All rights reserved.